JP Morgan Conference, page-3

We'll it would of been interesting getting to the conference and hearing pre day 1 keytruda is progressing with incyte to phase 3. I am not sure where that leaves us with Merck. The other interesting item in the announcement was the inference to good results that would be presented at a future conference for Merck and incyte.

I am looking forward to see what happens in 2.5 months, the charts don't mean anything to me. What good is the 1.00 if results are good or bad? Perhaps it will help us draw a dragon in the clouds that is charting.